Recall Issued for Blood Pressure Medication Due to Dissolution Issues

A comprehensive recall has been initiated for chlorthalidone tablets, a widely used treatment for high blood pressure, as these pills did not meet the dissolution criteria set by the FDA. The manufacturer, Inventia Healthcare, identified that over 13,000 bottles from the affected lot are not dissolving correctly, potentially leading to insufficient absorption of the active ingredient necessary for effective blood pressure management. The FDA categorized this as a Class II recall on September 17, which is a serious designation, warning that diminished efficacy in a blood pressure medication could result in patients being inadequately treated without clear warning signs. Affected individuals are advised to verify the batch number on their bottles immediately.
Disclosure:
This video contains stock footage and content created or enhanced using AI-assisted tools.

ai-generated